• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

轻度至中度新冠肺炎的急性症状在个体间及不同时间内具有高度异质性。

Acute Symptoms of Mild to Moderate COVID-19 Are Highly Heterogeneous Across Individuals and Over Time.

作者信息

Rodebaugh Thomas L, Frumkin Madelyn R, Reiersen Angela M, Lenze Eric J, Avidan Michael S, Miller J Philip, Piccirillo Jay F, Zorumski Charles F, Mattar Caline

机构信息

Department of Psychological and Brain Sciences, Washington University in St Louis, St Louis, Missouri, USA.

Department of Psychiatry, Washington University School of Medicine (WUSM), St Louis, Missouri, USA.

出版信息

Open Forum Infect Dis. 2021 Mar 1;8(3):ofab090. doi: 10.1093/ofid/ofab090. eCollection 2021 Mar.

DOI:10.1093/ofid/ofab090
PMID:33796601
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7989225/
Abstract

BACKGROUND

The symptoms of coronavirus disease 2019 (COVID-19) appear to be heterogenous, and the typical course of these symptoms is unknown. Our objectives were to characterize the common trajectories of COVID-19 symptoms and to assess how symptom course predicts other symptom changes as well as clinical deterioration.

METHODS

One hundred sixty-two participants with acute COVID-19 responded to surveys up to 31 times for up to 17 days. Several statistical methods were used to characterize the temporal dynamics of these symptoms. Because 9 participants showed clinical deterioration, we explored whether these participants showed any differences in symptom profiles.

RESULTS

Trajectories varied greatly between individuals, with many having persistently severe symptoms or developing new symptoms several days after being diagnosed. A typical trajectory was for a symptom to improve at a decremental rate, with most symptoms still persisting to some degree at the end of the reporting period. The pattern of symptoms over time suggested a fluctuating course for many patients. Participants who showed clinical deterioration were more likely to present with higher reports of severity of cough and diarrhea.

CONCLUSIONS

The course of symptoms during the initial weeks of COVID-19 is highly heterogeneous and is neither predictable nor easily characterized using typical survey methods. This has implications for clinical care and early-treatment clinical trials. Additional research is needed to determine whether the decelerating improvement pattern seen in our data is related to the phenomenon of patients reporting long-term symptoms and whether higher symptoms of diarrhea in early illness presages deterioration.

摘要

背景

2019冠状病毒病(COVID-19)的症状表现似乎具有异质性,且这些症状的典型病程尚不清楚。我们的目标是描述COVID-19症状的常见轨迹,并评估症状病程如何预测其他症状变化以及临床恶化情况。

方法

162名急性COVID-19患者接受了调查,调查最多进行31次,为期最长17天。使用了几种统计方法来描述这些症状的时间动态变化。由于9名患者出现了临床恶化,我们探讨了这些患者在症状特征上是否存在差异。

结果

个体之间的症状轨迹差异很大,许多人在被诊断后数天内症状持续严重或出现新症状。典型的轨迹是症状以递减的速率改善,在报告期结束时大多数症状仍在一定程度上持续存在。随着时间推移的症状模式表明许多患者的病程呈波动状。出现临床恶化的患者更有可能报告咳嗽和腹泻的严重程度较高。

结论

COVID-19最初几周的症状病程高度异质,使用典型的调查方法既无法预测也难以描述。这对临床护理和早期治疗临床试验具有重要意义。需要进一步研究以确定我们数据中看到的症状改善减速模式是否与患者报告长期症状的现象有关,以及疾病早期较高的腹泻症状是否预示着病情恶化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/711f/7990516/bbb9b21b6a41/ofab090_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/711f/7990516/3fb93d7d90e6/ofab090_iffig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/711f/7990516/6ad98b3786ea/ofab090_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/711f/7990516/badc25acc335/ofab090_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/711f/7990516/bbb9b21b6a41/ofab090_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/711f/7990516/3fb93d7d90e6/ofab090_iffig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/711f/7990516/6ad98b3786ea/ofab090_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/711f/7990516/badc25acc335/ofab090_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/711f/7990516/bbb9b21b6a41/ofab090_fig3.jpg

相似文献

1
Acute Symptoms of Mild to Moderate COVID-19 Are Highly Heterogeneous Across Individuals and Over Time.轻度至中度新冠肺炎的急性症状在个体间及不同时间内具有高度异质性。
Open Forum Infect Dis. 2021 Mar 1;8(3):ofab090. doi: 10.1093/ofid/ofab090. eCollection 2021 Mar.
2
Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.用于评估非住院轻中度 COVID-19 患者肠道微生物组调节的自然史和影响的虚拟化临床研究:一项随机、开放标签、前瞻性研究,平行组研究评估 KB109 对肠道微生物组结构和功能的生理影响:一项随机对照研究方案的结构化总结。
Trials. 2021 Apr 2;22(1):245. doi: 10.1186/s13063-021-05157-0.
3
Acute loss of smell and taste among patients with symptoms compatible with COVID-19.出现与COVID-19相符症状的患者中嗅觉和味觉急性丧失。
Dan Med J. 2020 Aug 6;67(9):A05200370.
4
Symptom Diary-Based Analysis of Disease Course among Patients with Mild Coronavirus Disease, Germany, 2020.基于症状日记的 2020 年德国轻症冠状病毒病患者病程分析。
Emerg Infect Dis. 2021 May;27(5):1353-1361. doi: 10.3201/eid2705.204507.
5
Universal testing for severe acute respiratory syndrome coronavirus 2 in 2 Philadelphia hospitals: carrier prevalence and symptom development over 2 weeks.在费城的 2 家医院进行的严重急性呼吸综合征冠状病毒 2 通用检测:2 周内的携带者流行率和症状发展。
Am J Obstet Gynecol MFM. 2020 Nov;2(4):100226. doi: 10.1016/j.ajogmf.2020.100226. Epub 2020 Sep 11.
6
Subjective Changes in Smell and Taste During the COVID-19 Pandemic: A National Survey-Preliminary Results.新冠疫情期间嗅觉和味觉的主观变化:全国性调查——初步结果。
Otolaryngol Head Neck Surg. 2020 Aug;163(2):302-306. doi: 10.1177/0194599820929957. Epub 2020 May 19.
7
Distorted chemosensory perception and female sex associate with persistent smell and/or taste loss in people with SARS-CoV-2 antibodies: a community based cohort study investigating clinical course and resolution of acute smell and/or taste loss in people with and without SARS-CoV-2 antibodies in London, UK.嗅觉和味觉障碍与女性性别相关,并与 SARS-CoV-2 抗体阳性者的持续性嗅觉和/或味觉丧失有关:一项基于社区的队列研究,在英国伦敦调查了 SARS-CoV-2 抗体阳性和阴性者急性嗅觉和/或味觉丧失的临床过程和恢复情况。
BMC Infect Dis. 2021 Feb 25;21(1):221. doi: 10.1186/s12879-021-05927-w.
8
App-Based Tracking of Self-Reported COVID-19 Symptoms: Analysis of Questionnaire Data.基于应用程序的自我报告新冠病毒症状追踪:问卷数据分析
J Med Internet Res. 2020 Sep 9;22(9):e21956. doi: 10.2196/21956.
9
Loss of Smell and Taste in Patients With Suspected COVID-19: Analyses of Patients' Reports on Social Media.嗅觉和味觉丧失的疑似 COVID-19 患者:社交媒体上患者报告的分析。
J Med Internet Res. 2021 Apr 22;23(4):e26459. doi: 10.2196/26459.
10
Analyzing Citizens' and Health Care Professionals' Searches for Smell/Taste Disorders and Coronavirus in Finland During the COVID-19 Pandemic: Infodemiological Approach Using Database Logs.分析 COVID-19 大流行期间芬兰公民和医疗保健专业人员对嗅觉/味觉障碍和冠状病毒的搜索:使用数据库日志的信息流行病学方法。
JMIR Public Health Surveill. 2021 Dec 7;7(12):e31961. doi: 10.2196/31961.

引用本文的文献

1
Prescription rates in different groups of outpatients with covid-19 and other acute respiratory infections: comparative observational study based on German routine data.新冠病毒病及其他急性呼吸道感染不同门诊患者群体的处方率:基于德国常规数据的比较观察性研究
BMJ Med. 2025 Sep 4;4(1):e000992. doi: 10.1136/bmjmed-2024-000992. eCollection 2025.
2
Patient-Reported Outcomes in COVID-19 Treatment with Monoclonal Antibodies Reveal Benefits in Return to Usual Activities.新冠病毒治疗中使用单克隆抗体的患者报告结局显示在恢复日常活动方面有获益。
Infect Dis Ther. 2024 Aug;13(8):1861-1876. doi: 10.1007/s40121-024-01013-1. Epub 2024 Jul 3.
3

本文引用的文献

1
Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial.氟伏沙明对比安慰剂在伴有症状的 COVID-19 门诊患者中的临床恶化:一项随机临床试验。
JAMA. 2020 Dec 8;324(22):2292-2300. doi: 10.1001/jama.2020.22760.
2
Symptoms of COVID-19 Outpatients in the United States.美国新冠肺炎门诊患者的症状。
Open Forum Infect Dis. 2020 Jun 30;7(7):ofaa271. doi: 10.1093/ofid/ofaa271. eCollection 2020 Jul.
3
Characterization of Prolonged COVID-19 Symptoms in an Outpatient Telemedicine Clinic.
SPIKENET: An Evidence-Based Therapy for Long COVID.
SPIKENET:长新冠的循证疗法。
Viruses. 2024 May 24;16(6):838. doi: 10.3390/v16060838.
4
Activation of the MAPK network provides a survival advantage during the course of COVID-19-induced sepsis: a real-world evidence analysis of a multicenter COVID-19 Sepsis Cohort.丝裂原活化蛋白激酶(MAPK)网络的激活在新型冠状病毒肺炎(COVID-19)诱发的脓毒症病程中提供了生存优势:一项多中心COVID-19脓毒症队列的真实世界证据分析
Infection. 2025 Feb;53(1):107-115. doi: 10.1007/s15010-024-02325-7. Epub 2024 Jun 19.
5
A systematic review and meta-analysis, investigating dose and time of fluvoxamine treatment efficacy for COVID-19 clinical deterioration, death, and Long-COVID complications.一项系统评价和荟萃分析,研究了氟伏沙明治疗 COVID-19 病情恶化、死亡和长期 COVID 并发症的剂量和时间疗效。
Sci Rep. 2024 Jun 12;14(1):13462. doi: 10.1038/s41598-024-64260-9.
6
Characterizing health-related quality of life and identifying disease predictors among patients suspected of having long COVID: an analysis of COMET-ICE clinical trial data.描述疑似长新冠患者的健康相关生活质量并识别疾病预测因素:COMET-ICE 临床试验数据的分析。
Front Public Health. 2024 May 9;12:1278106. doi: 10.3389/fpubh.2024.1278106. eCollection 2024.
7
Characteristics of long COVID in patients with autoimmune rheumatic diseases: a systematic review and meta-analysis.自身免疫性风湿病患者的长新冠特征:一项系统综述和荟萃分析。
Rheumatol Adv Pract. 2024 Mar 2;8(2):rkae027. doi: 10.1093/rap/rkae027. eCollection 2024.
8
Taste loss as a distinct symptom of COVID-19: a systematic review and meta-analysis.味觉丧失是 COVID-19 的一个独特症状:系统评价和荟萃分析。
Chem Senses. 2023 Jan 1;48. doi: 10.1093/chemse/bjad043.
9
The influence of meaningful work on the mental health of SME employees in the COVID-19 era: can coping strategies mediate the relationship?疫情时代中小企业员工的工作意义对其心理健康的影响:应对策略能否起到中介作用?
BMC Public Health. 2023 Dec 6;23(1):2435. doi: 10.1186/s12889-023-17347-3.
10
Daily disease severity in patients with COVID-19 admitted to the hospital: The SCODA (severity of coronavirus disease assessment) score.每日 COVID-19 住院患者疾病严重程度:SCODA(冠状病毒疾病严重程度评估)评分。
PLoS One. 2023 Sep 8;18(9):e0291212. doi: 10.1371/journal.pone.0291212. eCollection 2023.
门诊远程医疗诊所中新冠长期症状的特征分析
Open Forum Infect Dis. 2020 Sep 12;7(10):ofaa420. doi: 10.1093/ofid/ofaa420. eCollection 2020 Oct.
4
Fever Patterns, Cytokine Profiles, and Outcomes in COVID-19.新型冠状病毒肺炎的发热模式、细胞因子谱及预后
Open Forum Infect Dis. 2020 Aug 24;7(9):ofaa375. doi: 10.1093/ofid/ofaa375. eCollection 2020 Sep.
5
Clinical characteristics and predictors of the duration of SARS-CoV-2 viral shedding in 140 healthcare workers.140 名医护人员中 SARS-CoV-2 病毒脱落持续时间的临床特征和预测因素。
J Intern Med. 2020 Dec;288(6):725-736. doi: 10.1111/joim.13160. Epub 2020 Sep 21.
6
The Course of Mild and Moderate COVID-19 Infections-The Unexpected Long-Lasting Challenge.轻度和中度新冠病毒感染病程——意想不到的长期挑战
Open Forum Infect Dis. 2020 Jul 23;7(9):ofaa286. doi: 10.1093/ofid/ofaa286. eCollection 2020 Sep.
7
Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network - United States, March-June 2020.症状持续时间和多州医疗保健系统网络中 COVID-19 门诊患者恢复健康延迟的风险因素 - 美国,2020 年 3 月至 6 月。
MMWR Morb Mortal Wkly Rep. 2020 Jul 31;69(30):993-998. doi: 10.15585/mmwr.mm6930e1.
8
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.新型冠状病毒病 2019(COVID-19)的病理生理学、传播、诊断和治疗:综述。
JAMA. 2020 Aug 25;324(8):782-793. doi: 10.1001/jama.2020.12839.
9
Clinical characteristics and outcomes of COVID-19 patients with gastrointestinal symptoms admitted to Jianghan Fangcang Shelter Hospital in Wuhan, China.中国武汉江汉方仓庇护医院收治的具有胃肠道症状的 COVID-19 患者的临床特征和结局。
J Med Virol. 2020 Nov;92(11):2735-2741. doi: 10.1002/jmv.26146. Epub 2020 Jul 14.
10
Objective olfactory evaluation of self-reported loss of smell in a case series of 86 COVID-19 patients.目的:对 86 例 COVID-19 患者的嗅觉自我报告丧失病例系列进行客观嗅觉评估。
Head Neck. 2020 Jul;42(7):1583-1590. doi: 10.1002/hed.26279. Epub 2020 May 21.